Regenerative Wound Care. Alongside Your Diabetologist and Vascular Surgeon.
An integrative, physician-supervised programme for Indian adults living with diabetic foot ulcers, chronic non-healing wounds or recurrent foot ulceration. Anchored by ALIV's PRP for Diabetic Foot, layered with glycemic and metabolic optimisation, micronutrient repletion, structured wound care and autologous cell therapy in selected cases. Built alongside your diabetology and vascular team. Active infection or critical limb ischemia requires primary specialist management first.
Doctor-led. Reproductive-medicine-coordinated. Pune and Mumbai.
Personalised programme. Comprehensive preconception workup. Built around your biology, age and stage.
Outcomes vary. ALIV does not guarantee conception, IVF success, pregnancy or live birth. Reproductive endocrinology remains primary.
Regenerative Wound Care. Alongside Your Diabetologist and Vascular Surgeon.
An integrative, physician-supervised programme for Indian adults living with diabetic foot ulcers, chronic non-healing wounds or recurrent foot ulceration. Anchored by ALIV's PRP for Diabetic Foot, layered with glycemic and metabolic optimisation, micronutrient repletion, structured wound care and autologous cell therapy in selected cases. Built alongside your diabetology and vascular team. Active infection or critical limb ischemia requires primary specialist management first.
Doctor-led. Reproductive-medicine-coordinated. Pune and Mumbai.
Personalised programme. Comprehensive preconception workup. Built around your biology, age and stage.
Outcomes vary. ALIV does not guarantee conception, IVF success, pregnancy or live birth. Reproductive endocrinology remains primary.
Diabetic foot disease is multi-factor: hyperglycemia impairs every step of normal wound healing, microvascular disease reduces blood supply, neuropathy removes protective sensation, chronic inflammation persists. The protocol addresses each and adds regenerative growth factor delivery directly to the wound.
Full ulcer characterisation (depth, size, infection, Wagner/IDSA stage), vascular assessment (ABI where indicated), neuropathy testing, HbA1c, lipid panel, kidney function, micronutrient status, infection screen.
Autologous platelet-rich plasma delivering PDGF, VEGF, TGF-β, EGF, FGF directly to the wound bed. Multiple SR/MAs of RCTs show PRP significantly improves DFU healing rate and shortens healing time vs conventional care alone. Applied as injection around wound margins or topical/gel application across the healing period.
Wound healing in diabetes is fundamentally dependent on glycemic control. Coordinates with the Advanced Metabolic Reset Protocol where appropriate (including Tirzepatide microdose pathway). Targeted micronutrient repletion: vitamin D, zinc, vitamin C, B-complex, protein adequacy.
Standard wound care (debridement, advanced dressings, offloading) coordinated with your treating team. Active infection requires antibiotic management. Thymosin Alpha-1 can be added for clients with recurrent infections, immune dysregulation or stubborn slow-healing wounds.
Investigational. Reserved for large chronic wounds, failed conventional approaches or post-amputation residual ulceration after PRP optimisation.
Daily foot care and prevention are clinical interventions, not optional.
Q. How is this different from what my diabetologist or surgeon is already doing?
A. It complements, not replaces. Your diabetologist manages glycemic control; your surgeon manages wound debridement and surgical decisions. ALIV adds the regenerative layer (PRP for Diabetic Foot) plus integrated metabolic and lifestyle support.
Q. How strong is the evidence for PRP in diabetic foot ulcers?
A. Strong. Multiple meta-analyses of RCTs (the highest tier of clinical evidence) demonstrate that PRP significantly improves healing rate and shortens healing time compared to conventional care alone.
Q. Can PRP help me avoid amputation?
A. Honest answer: it can improve healing outcomes and may help avoid amputation in some cases, but it cannot guarantee that. PRP is most effective when introduced before tissue loss has progressed too far.
Q. What about my blood thinners?
A. Many diabetic patients are on antiplatelet or anticoagulant medication. PRP can usually still be performed but requires careful timing and physician coordination.
Q. Who should not do this protocol?
A. Active uncontrolled infection requiring inpatient management; critical limb ischemia requiring urgent vascular intervention; severe uncontrolled hyperglycemia requiring stabilisation first; clients seeking to bypass appropriate diabetology or surgical care.
Diabetic foot ulcers are one of the most serious complications of diabetes, with a 6.2% pooled prevalence in Indian adults with diabetes. ALIV's Diabetic Foot Protocol layers PRP for Diabetic Foot (RCT-supported) onto glycemic optimisation, wound care and lifestyle support. Doctor-led at Pune and Mumbai.
Workup (ulcer staging, vascular and neuropathy assessment, micronutrient and infection screen), PRP for Diabetic Foot as lead intervention, glycemic and metabolic foundation (with Advanced Metabolic Reset coordination), wound care and infection management (with Tα1 for recurrent or immune-driven cases), and ACT or exosomes in selected advanced cases.
Integrative, not alternative. Active infection requires antibiotic management. Critical limb ischemia requires vascular surgery. All prescribed medications must continue as directed.
Adults with active DFU, chronic non-healing wound, post-amputation residual ulceration, history of recurrent ulceration, or diabetic peripheral neuropathy with foot deformity.
PRP for Diabetic Foot is one of the better-evidenced regenerative therapies in chronic wound care. ALIV combines it with the metabolic and lifestyle foundation that determines healing.